Dr Brendon Chua is a viral and translational immunologist who completed his PhD at the University of Melbourne. His research focuses on defining innate and adaptive immune-mediated mechanisms that underpin the control of respiratory viral infections, including influenza and SARS-CoV-2, and translating these findings into commercial outcomes. He has held research positions at Monash University, the Ludwig Institute for Cancer Research and the CRC for Polymers, as well as placements in the vaccine industry. He is also an affiliated Associate Professor of Hokkaido University and leading member of Japan’s Global Institute of Collaborative Research & Education (GI-CoRE) consortium.
